{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:33:15Z","timestamp":1785429195209,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T00:00:00Z","timestamp":1684713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Eat Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>There is emerging evidence that stimulants warrant further investigation as a treatment for bulimia nervosa (BN) including a recent open-label feasibility trial examining the use of lisdexamfetamine dimestylate (LDX) for BN. The current report presents the secondary outcomes and qualitative interview results from that feasibility trial. These outcomes explore several purported mechanisms that may explain how stimulants affect symptoms of BN: appetite, impulsivity, obsessive and compulsive symptoms, eating disorder psychopathology\/impairment and reward-based decision-making.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Twenty-three participants with BN received LDX for eight weeks. Questionnaires assessing appetite, impulsivity, obsessive and compulsive symptoms, eating disorder psychopathology and impairment were administered at baseline and post-treatment. Participants also completed a two-step reinforcement learning task to assess their decision-making. Semi-structured interviews took place at baseline, week 5, and follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Reductions in hunger, food-related impulsivity, obsessive and compulsive features, eating disorder psychopathology and impairment were found. However, reward learning, as far as it is assessed by the task, did not seem to contribute to the effect of LDX on BN symptoms. Qualitative analysis suggested four themes: (1) reprieve from the eating disorder, (2) improvement in function and quality of life, (3) renewed hope for recovery, and (4) ability to normalize eating.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This report suggests several potential mechanisms by which LDX may reduce symptoms of binging and purging in those with BN. Importantly, due to the open-label design, we are unable to attribute findings to the medication. Instead, our results should be interpreted as hypothesis generating to inform future studies such as adequately powered randomized controlled trials.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic> NCT03397446.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40337-023-00796-x","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T14:02:40Z","timestamp":1684764160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa"],"prefix":"10.1186","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct03397446","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Laura","family":"Dixon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bartel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarrah I.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Gamberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"McElroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Keshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,22]]},"reference":[{"issue":"6","key":"796_CR1","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1017\/S0033291718003525","volume":"49","author":"J Svaldi","year":"2019","unstructured":"Svaldi J, Schmitz F, Baur J, Hartmann AS, Legenbauer T, Thaler C, et al. Efficacy of psychotherapies and pharmacotherapies for bulimia nervosa. Psychol Med. 2019;49(6):898\u2013910.","journal-title":"Psychol Med"},{"issue":"3","key":"796_CR2","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/eat.23650","volume":"55","author":"A Keshen","year":"2022","unstructured":"Keshen A, Bartel S, Frank GKW, Svedlund NE, Nunes A, Dixon L, et al. The potential role of stimulants in treating eating disorders. Int J Eat Disord. 2022;55(3):318\u201331.","journal-title":"Int J Eat Disord"},{"issue":"3","key":"796_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jamapsychiatry.2014.2162","volume":"72","author":"SL McElroy","year":"2015","unstructured":"McElroy SL, Hudson JI, Mitchell JE, Wilfley D, Ferreira-Cornwell MC, Gao J, et al. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial. JAMA Psychiatry. 2015;72(3):235\u201346.","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"796_CR4","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/eat.23480","volume":"03","author":"AR Keshen","year":"2021","unstructured":"Keshen AR, Dixon L, Ali SI, Helson T, Nunes A, Milliken H, et al. A feasibility study evaluating lisdexamfetamine dimesylate for the treatment of adults with bulimia nervosa. Int J Eat Disord. 2021;03(5):872\u20138.","journal-title":"Int J Eat Disord"},{"issue":"3","key":"796_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/erv.2418","volume":"24","author":"SL McElroy","year":"2016","unstructured":"McElroy SL, Mitchell JE, Wilfley D, Gasior M, Ferreira-Cornwell MC, McKay M, et al. Lisdexamfetamine dimesylate effects on binge eating behaviour and obsessive\u2013compulsive and impulsive features in adults with binge eating disorder. Eur Eat Disord Rev. 2016;24(3):223\u201331.","journal-title":"Eur Eat Disord Rev"},{"key":"796_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.euroneuro.2021.08.001","volume":"53","author":"E Schneider","year":"2021","unstructured":"Schneider E, Higgs S, Dourish CT. Lisdexamfetamine and binge-eating disorder: a systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder. Eur Neuropsychopharmacol. 2021;53:49\u201378.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"796_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.biopsych.2008.09.028","volume":"65","author":"A Schienle","year":"2009","unstructured":"Schienle A, Sch\u00e4fer A, Hermann A, Vaitl D. Binge-eating disorder: reward sensitivity and brain activation to images of food. Biol Psychiatry. 2009;65(8):654\u201361.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"796_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1177\/0269881116647506","volume":"30","author":"DJ Heal","year":"2016","unstructured":"Heal DJ, Goddard S, Brammer RJ, Hutson PH, Vickers SP. Lisdexamfetamine reduces the compulsive and perseverative behaviour of binge-eating rats in a novel food reward\/punished responding conflict model. J Psychopharmacol. 2016;30(7):662\u201375.","journal-title":"J Psychopharmacol"},{"key":"796_CR9","doi-asserted-by":"publisher","first-page":"172851","DOI":"10.1016\/j.pbb.2020.172851","volume":"189","author":"RE Presby","year":"2020","unstructured":"Presby RE, Rotolo RA, Yang JH, Correa M, Salamone JD. Lisdexamfetamine suppresses instrumental and consummatory behaviors supported by foods with varying degrees of palatability: exploration of a binge-like eating model. Pharmacol Biochem Behav. 2020;189:172851.","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"796_CR10","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1177\/0269881117691672","volume":"31","author":"SP Vickers","year":"2017","unstructured":"Vickers SP, Goddard S, Brammer RJ, Hutson PH, Heal DJ. Investigation of impulsivity in binge-eating rats in a delay-discounting task and its prevention by the d-amphetamine prodrug, lisdexamfetamine. J Psychopharmacol. 2017;31(6):784\u201397.","journal-title":"J Psychopharmacol"},{"issue":"6","key":"796_CR11","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton JH, Stanford MS, Barratt ES. Factor structure of the barratt impulsiveness scale. J Clin Psychol. 1995;51(6):768\u201374.","journal-title":"J Clin Psychol"},{"issue":"8","key":"796_CR12","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1002\/eat.22932","volume":"51","author":"S Griffiths","year":"2018","unstructured":"Griffiths S, Mitchison D, Murray SB, Mond JM, Bastian BB. How might eating disorders stigmatization worsen eating disorders symptom severity? Evaluation of a stigma internalization model. Int J Eat Disord. 2018;51(8):1010\u20134.","journal-title":"Int J Eat Disord"},{"issue":"2\/3","key":"796_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1023\/A:1013689704352","volume":"47","author":"P Auer","year":"2002","unstructured":"Auer P, Cesa-Bianchi N, Fischer P. Finite-time analysis of the multiarmed bandit problem. Mach Learn. 2002;47(2\/3):235\u201356.","journal-title":"Mach Learn"},{"issue":"2","key":"796_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00213-011-2563-2","volume":"219","author":"S de Wit","year":"2012","unstructured":"de Wit S, Standing HR, DeVito EE, Robinson OJ, Ridderinkhof KR, Robbins TW, et al. Reliance on habits at the expense of goal-directed control following dopamine precursor depletion. Psychopharmacology. 2012;219(2):621\u201331.","journal-title":"Psychopharmacology"},{"issue":"8","key":"796_CR15","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/nn.2342","volume":"12","author":"MJ Frank","year":"2009","unstructured":"Frank MJ, Doll BB, Oas-Terpstra J, Moreno F. Prefrontal and striatal dopaminergic genes predict individual differences in exploration and exploitation. Nat Neurosci. 2009;12(8):1062\u20138.","journal-title":"Nat Neurosci"},{"issue":"1","key":"796_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ima.22387","volume":"30","author":"T Wang","year":"2020","unstructured":"Wang T, Wu X, Jiang J, Liu C, Zhu M. Functional neural interactions during adaptive reward learning: an functional magnetic resonance imaging study. Int J Imaging Syst Technol. 2020;30(1):92\u2013103.","journal-title":"Int J Imaging Syst Technol"},{"issue":"2","key":"796_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5014\/ajot.2013.006270","volume":"1","author":"L Tickle-Degnen","year":"2013","unstructured":"Tickle-Degnen L. Nuts and bolts of conducting feasibility studies. Am J Occup Ther. 2013;1(2):171\u20136.","journal-title":"Am J Occup Ther"},{"key":"796_CR18","unstructured":"Dixon L. Exploring the use of lisdexamfetamine dimesylate as a treatment for adults with bulimia nervosa: A quantitative and qualitative assessment [Internet] [Master\u2019s thesis]. [Halifax, Nova Scotia]: Dalhousie University; 2021. Available from: http:\/\/hdl.handle.net\/10222\/80739."},{"issue":"1","key":"796_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0022-3999(85)90010-8","volume":"29","author":"AJ Stunkard","year":"1985","unstructured":"Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985;29(1):71\u201383.","journal-title":"J Psychosom Res"},{"issue":"7","key":"796_CR20","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1002\/eat.22407","volume":"48","author":"LS Deal","year":"2015","unstructured":"Deal LS, Wirth RJ, Gasior M, Herman BK, McElroy SL. Validation of the yale-brown obsessive compulsive scale modified for binge eating. Int J Eat Disord. 2015;48(7):994\u20131004.","journal-title":"Int J Eat Disord"},{"key":"796_CR21","unstructured":"Fairburn CG, Cooper Z, O\u2019Connor M. Eating Disorder Examination (Edition 17.0D) [Internet]. 2014 [cited 2021 Apr 21]. Available from: https:\/\/www.credo-oxford.com\/pdfs\/EDE_17.0D.pdf."},{"issue":"3","key":"796_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/eat.20931","volume":"45","author":"KC Berg","year":"2012","unstructured":"Berg KC, Peterson CB, Frazier P, Crow SJ. Psychometric evaluation of the eating disorder examination and eating disorder examination-questionnaire: a systematic review of the literature. Int J Eat Disord. 2012;45(3):428\u201338.","journal-title":"Int J Eat Disord"},{"key":"796_CR23","unstructured":"Bohn K, Fairburn C. The clinical impairment assessment questionnaire (CIA 3.0). Cognitive Behavior Therapy and Eating Disorders.Guilford Press; 2008."},{"issue":"8","key":"796_CR24","doi-asserted-by":"publisher","first-page":"e1005090","DOI":"10.1371\/journal.pcbi.1005090","volume":"12","author":"W Kool","year":"2016","unstructured":"Kool W, Cushman FA, Gershman SJ. When does model-based control pay off? PLOS Comput Biol. 2016;12(8):e1005090.","journal-title":"PLOS Comput Biol"},{"issue":"2","key":"796_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"key":"796_CR26","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.eatbeh.2015.05.012","volume":"18","author":"R Elran-Barak","year":"2015","unstructured":"Elran-Barak R, Sztainer M, Goldschmidt AB, Crow SJ, Peterson CB, Hill LL, et al. Dietary restriction behaviors and binge eating in anorexia nervosa, bulimia nervosa and binge eating disorder: trans-diagnostic examination of the restraint model. Eat Behav. 2015;18:192\u20136.","journal-title":"Eat Behav"},{"key":"796_CR27","doi-asserted-by":"publisher","first-page":"716010","DOI":"10.3389\/fpsyg.2021.716010","volume":"12","author":"KR Griffiths","year":"2021","unstructured":"Griffiths KR, Apar\u00edcio L, Braund TA, Yang J, Harvie G, Harris A, et al. Impulsivity and its relationship with lisdexamfetamine dimesylate treatment in binge eating disorder. Front Psychol. 2021;12:716010.","journal-title":"Front Psychol"},{"key":"796_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.physbeh.2017.03.016","volume":"174","author":"P S\u00f6dersten","year":"2017","unstructured":"S\u00f6dersten P, Bergh C, Leon M, Brodin U, Zandian M. Cognitive behavior therapy for eating disorders versus normalization of eating behavior. Physiol Behav. 2017;174:178\u201390.","journal-title":"Physiol Behav"},{"key":"796_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.neubiorev.2016.01.013","volume":"63","author":"RM Kessler","year":"2016","unstructured":"Kessler RM, Hutson PH, Herman BK, Potenza MN. The neurobiological basis of binge-eating disorder. Neurosci Biobehav Rev. 2016;63:223\u201338.","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"796_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/erv.2214","volume":"21","author":"AM Lampard","year":"2013","unstructured":"Lampard AM, Tasca GA, Balfour L, Bissada H. An evaluation of the transdiagnostic cognitive-behavioural model of eating disorders: cognitive-behavioural model of eating disorders. Eur Eat Disord Rev. 2013;21(2):99\u2013107.","journal-title":"Eur Eat Disord Rev"},{"issue":"4","key":"796_CR31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1037\/0022-006X.61.4.696","volume":"61","author":"CG Fairburn","year":"1993","unstructured":"Fairburn CG, Peveler RC, Jones R, Hope RA, Doll HA. Predictors of 12-month outcome in bulimia nervosa and the influence of attitudes to shape and weight. J Consult Clin Psychol. 1993;61(4):696\u20138.","journal-title":"J Consult Clin Psychol"},{"issue":"2","key":"796_CR32","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/1098-108X(200009)28:2<209::AID-EAT10>3.0.CO;2-L","volume":"28","author":"Z Steel","year":"2000","unstructured":"Steel Z, Jones J, Adcock S, Clancy R, Bridgford-West L, Austin J. Why the high rate of dropout from individualized cognitive-behavior therapy for bulimia nervosa? Int J Eat Disord. 2000;28(2):209\u201314.","journal-title":"Int J Eat Disord"}],"updated-by":[{"DOI":"10.1186\/s40337-023-00926-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000}}],"container-title":["Journal of Eating Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-023-00796-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40337-023-00796-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40337-023-00796-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T16:05:00Z","timestamp":1700150700000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeatdisord.biomedcentral.com\/articles\/10.1186\/s40337-023-00796-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1186\/s40337-023-00796-x","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s40337-023-00926-5","asserted-by":"object"}]},"ISSN":["2050-2974"],"issn-type":[{"value":"2050-2974","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,22]]},"assertion":[{"value":"5 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s40337-023-00926-5","URL":"https:\/\/doi.org\/10.1186\/s40337-023-00926-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research conformed to the International Conference of Harmonization and Good Clinical Practice guidelines and was approved by Health Canada and the Nova Scotia Health Research Ethics Board (File no. 1023099). All participants provided written informed consent for participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ARK has been a member of scientific advisory boards, participated in speaker events and received educational grant support from Takeda Inc. and Otsuka\/Lundbeck. AK has been a member of scientific advisory boards and participated in speaker events from Takeda Inc. SLM has been a consultant to, or member of, the scientific advisory board of Avanir, Bracket, F. Hoffmann-La Roche Ltd., Idorsia, Mitsubishi Tanabe Pharma Corporation, Myriad, Naurex, Novo Nordisk, Otsuka, Shire, Sunovion, and Takeda (Shire); has been a principal or co-investigator on studies sponsored by Alkermes, Allergan, Avanir, Azevan, Forest, Marriott Foundation, Medibio, Myriad, National Institute of Mental Health, Naurex, Neurocrine, Novo Nordisk, Shire, Sunovion, and Takeda Pharmaceutical Company Limited; and is an inventor on United States Patent No. 6,323,236 B2, Use of Sulfamate Derivatives for Treating Impulse Control Disorders, and along with the patent\u2019s assignee, University of Cincinnati, Cincinnati, Ohio, has received payments from Johnson & Johnson, which has exclusive rights under the patent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}